Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Modified Research Career Development Award (K04)
Project #
5K04CA001497-04
Application #
3071950
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1990-09-01
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Pharmacy
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Song, D; Wientjes, M G; Au, J L (1997) Isocratic high-performance liquid chromatographic determination of thiacetazone by direct injection of plasma into an internal surface reversed-phase column. J Chromatogr B Biomed Sci Appl 690:289-94
Weaver, J R; Au, J L (1997) Comparative scoring by visual and image analysis of cells in human solid tumors labeled for proliferation markers. Cytometry 27:189-99
Kang, H J; Wientjes, M G; Au, J L (1997) Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine. Pharm Res 14:337-44
Song, D; Wientjes, M G; Au, J L (1997) Bladder tissue pharmacokinetics of intravesical taxol. Cancer Chemother Pharmacol 40:285-92
Yeh, T K; Kang, H J; Wientjes, M G et al. (1996) Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats. Pharm Res 13:628-32
Song, D; Au, J L (1996) Direct injection isocratic high-performance liquid chromatographic analysis of mitomycin C in plasma. J Chromatogr B Biomed Appl 676:165-8
Yen, W C; Schmittgen, T; Au, J L (1996) Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures. Pharm Res 13:1887-91
Yen, W C; Wientjes, M G; Au, J L (1996) Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics. Pharm Res 13:1305-12
Gan, Y; Wientjes, M G; Badalament, R A et al. (1996) Pharmacodynamics of doxorubicin in human bladder tumors. Clin Cancer Res 2:1275-83
Wientjes, M G; Badalament, R A; Au, J L (1996) Penetration of intravesical doxorubicin in human bladders. Cancer Chemother Pharmacol 37:539-46

Showing the most recent 10 out of 41 publications